There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Rutgers Researchers Revive Decades-Old Pregnancy Cohort with Modern Scientific Potential.
- Hidden in Plain Sight: The Chemical Burden of Personal Care Products.
- Unraveling the Mysteries of Male Infertility.
- What’s next for COVID? Experts weigh in, 5 years after it first appeared.
- New NJACTS Publication
Categories
- Community (2,195)
- Covid (983)
- CTO Events (6)
- News (2,802)
- Pilots (21)